Literature DB >> 9421291

Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.

K L MacDonell1, J Diamond.   

Abstract

1. It has been suggested that activation of cyclic GMP-dependent protein kinase (PKG) is a necessary step in the chain of events leading to the production of negative inotropy by muscarinic receptor agonists in mammalian ventricles, and that some cyclic GMP-elevating agents, such as sodium nitroprusside (SNP), fail to exert a negative inotropic effect because they elevate cyclic GMP levels in a pool that does not activate the kinase. This hypothesis was tested in the present study by monitoring the effects of carbachol, SNP and atrial natriuretic peptide (ANP) on contractility, cyclic GMP content and PKG activity in rat intact ventricular preparations and freshly isolated ventricular cardiomyocytes. 2. The presence of PKG in both the intact vehicle and in isolated ventricular cardiomyocytes was confirmed by MonoQ anion exchange chromatography and Western blotting. The elution profile indicated that the conditions of the PKG assay were selective for measuring PKG activity. 3. Carbachol induced a marked negative inotropic effect in intact, perfused hearts and ventricular strips in the presence of isoproterenol. The negative inotropic effect of carbachol was not associated with significant changes in cyclic GMP content or PKG activity in intact ventricular tissue, or in PKG activity in isolated cardiomyocytes. 4. SNP and ANP significantly increased cyclic GMP levels and activated PKG in intact ventricular preparations. Both drugs also activated PKG in isolated cardiomyocytes. However, neither drug had any negative inotropic effect in isoprenaline-stimulated perfused hearts and ANP did not change the contractility of isoprenaline-stimulated isolated cardiomyocytes. 5. The results of this study demonstrate that the negative inotropic effects of muscarinic receptor agonists can occur in the absence of significant activation of PKG. Conversely, marked increases in ventricular cyclic GMP content and PKG activity caused by SNP or ANP were not accompanied by a negative inotropic effect. 6. These results suggest that increases in cyclic GMP levels and activation of PKG do not play important roles in the regulation of rat ventricular contractility by muscarinic receptor agonists.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9421291      PMCID: PMC1565065          DOI: 10.1038/sj.bjp.0701492

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Peroxynitrite is a positive inotropic agent in atrial and ventricular fibres of the frog heart.

Authors:  J M Chesnais; R Fischmeister; P F Mery
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

2.  Effects of C-type natriuretic peptide on rat cardiac contractility.

Authors:  J M Brusq; E Mayoux; L Guigui; J Kirilovsky
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

3.  Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of the frog heart.

Authors:  J M Chesnais; R Fischmeister; P F Méry
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

4.  Nitric oxide effects depend on different mechanisms in different regions of the rat heart.

Authors:  Kursat Derici; Ufuk Samsar; Emine Demirel-Yilmaz
Journal:  Heart Vessels       Date:  2011-02-11       Impact factor: 2.037

5.  G protein-mediated inhibitory effect of a nitric oxide donor on the L-type Ca2+ current in rat ventricular myocytes.

Authors:  N Abi-Gerges; R Fischmeister; P F Méry
Journal:  J Physiol       Date:  2001-02-15       Impact factor: 5.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.